Primary neural leprosy: Systematic review;Hanseníase neural primária: Revisão sistemática

Arquivos de Neuro-Psiquiatria

Volumn 71, Issue 6, 2013, Pages 397-404

  Garbino, José Antonio ^a   Marques, Wilson ^b   Barreto, Jaison Antonio ^a   Otto Heise, Carlos ^b   Jardim Rodrigues, Márcia Maria ^c   Antunes, Sérgio L ^c   Soares, Cleverson Teixeira ^a   Cesar Floriano, Marcos ^d   Nery, José Augusto ^c   Bianconcini Trindade, Maria Angela ^e   Barbosa Carvalho, Noêmia ^f   de Andrada, Nathália Carvalho ^f   Antunes Barreira, Amilton ^b   Virmond, Marcos da Cunha Lopes ^a  

^a INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e Secretaria de Estado da Saude   (Brazil)

^f Associação Médica Brasileira   (Brazil)

Author keywords

Diagnosis; Leprosy; Neuropathy; Systematic review

Indexed keywords

CLOFAZIMINE; DAPSONE; PLACEBO; RIFAMPICIN; STEROID;

DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEPROMIN TEST; LEPROSY; MONONEUROPATHY; MONONEUROPATHY MULTIPLEX; MYCOBACTERIUM LEPRAE; NERVE BIOPSY; NERVE CONDUCTION; NEUROPATHY; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSIBILITY; SKIN BIOPSY; SKIN DEFECT; SYSTEMATIC REVIEW;

EID: 84880370398     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20130046     Document Type: Review

References (59)

1. Wade HW. The classification documents and symposium. Editorial Int J Lepr 1952;20:513-520.
2. Browne SG. Some less common neurological findings in leprosy. J Neurol Sci 1965;2:253-261.
3. Singh G, Dash K, Grover S, Sangolli P. Skin patches heralding 4 relapse in a treated case of neuritic leprosy. Lepr Rev 1998;64:400-401.
4. Garbino JA. O paciente com suspeita de hanseníase primariamente neural. Hansen Int 2007;32:203-206.
5. Noordeen, SK. Epidemiology of (poly) neuritic type of leprosy. Lepr India 1972;4490-4496.
6. Dongre VV, Ganapati R, Chulawala RG. A study of mono-neuritic lesions in a leprosy clinic. Lepr India 1976;48:132-137.
7. Suneetha S, Sigamoni A, Kurian N, Chacko CJ. The development of cutaneous lesions during follow-up of patients with primary neuritic leprosy. Int J Dermatol 2005;44:224-229.
8. Mishra B, Mukherjee A, Girdhar A, Husain S, Malaviya GN, Girdhar BK. Neuritic leprosy: further progression and significance. Acta Leprol 1995;9:187-194.
9. Guilloton L, Drouet A, Combemale P, Cruel T, Dupin M, Ribot C. Neuritic leprosy disclosed by reversal reaction. Rev Neurol (Paris) 2002;158:84-86.
10. Dharmendra RK. Classification of leprosy. In: Hastings RC (ed). Leprosy. 2nd ed. New York: Churchill Livingstone; 1994, p. 179-190.
11. Kaur G, Girdhar BK, Girdhar A, et al. A clinical, immunological, and histological study of neuritic leprosy patients. Int J Lepr Other Mycobact Dis 1991;59:385-391.
12. Kumar B, Kaur I, Dogra S, Kumaran MS. Pure polyneuritic leprosy in India: an appraisal. Int J Lepr 2004;72:284-290.
13. Garbino JA, Ura S, Belone AFF, Marciano LHSC, Fleury RN. Clinical and diagnostic aspects of the primarily neural leprosy. Hansen Int 2004;29:130-136.
14. Brasil. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Guia para o Controle da hanseníase. Brasília: Ministério da Saúde; 2002.
15. Dos Santos CBA. Estudo da distribuição da perda sensitiva na hanseníase. [dissertação]. Ribeirão Preto (SP): Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo; 2010.
16. Almeida EC, Martinez AN, Maniero VC, et al. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood and nasal secretion of Brazilian household contacts. Mem Inst Oswaldo Cruz 2004;99:509-511.
17. Suneetha S, Arunthathi S, Kurian N, Chacko CJ. Histological changes in the nerve, skin and nasal mucosa of patients with primary neuritic leprosy. Acta Leprol 2000-2001;12:11-18.
18. Menicucci LA, Miranda A, Antunes SL, et al. Microscopic leprosy skin lesions in primary neuritic leprosy. J Am Acad Dermatol 2005;52:648-652.
19. Mitsuda K. On the value of a skin reaction to a suspension of leprous nodules. Int J Lepr 1953;21:347-358.
20. Rotberg A. Some aspects of immunity in leprosy and their importance in epidemiology, pathogenesis and classification of forms of the disease: based on 1529 lepromin tested cases. Rev Bras Leprol 1937;5:45-97.
21. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five group system. Int J Lepr 1966;34:255-273.
22. Uplekar MW, Antia NH. Clinical and histopathological observations on pure neuritic leprosy. Indian J Lepr 1986;58:513-521.
23. Maeda SM, Rotta O, Michalany NS, Camargo ZP, Sunderkötter C, Tomimori-Yamashita J. Comparison between anti-pgl-1 serology and Mitsuda reaction: clinical reading, microscopic findings and immunohistochemical analysis. Lepr Rev 2003;74:263-274.
24. Van Brakel WH, Khawas IB. Nerve damage in leprosy: an epidemiological and clinical study of 396 patients in West Nepal - Part 1. Definitions, methods and frequencies. Lepr Rev 1994;75:242-253.
25. Ramadan W, Mourad B, Fadel W, Ghoraba E. Clinical, electrophysiological, and immunopathological study of peripheral nerves in Hansen's disease. Lepr Rev 2001;72:35-49.
26. Jardim MR, Antunes SL, Santos AR, et al. Criteria for diagnosis of pure neural leprosy. J Neurol 2003;250:806-809.
27. Van Brakel WH, Nicholls PG, Das L, et al. The INFIR cohort study: investigating prediction, detection, and pathogenesis of neuropathy and reaction in leprosy. Methods and baseline of a cohort of multibacillary leprosy patients in North Índia. Lepr Rev 2005;76:14-34.
28. Jardim MR, Chimelli L, Faria SCR, et al. Clinical, electroneuromyographic and morphological studies of pure neural leprosy in a Brazilian referral centre. Lepr Rev 2004;75:242-253.
29. Jardim MR, Illarramendi X, Nascimento OJM, et al. Pure neural leprosy: steroids prevent neuropathy progression. Arq Neuropsiquiatr 2007;65:969-973.
30. McDougall AC, Harman DJ, Waudby H, Hargrave JC. Peripheral nerve biopsies in the diagnosis of leprosy in Aboriginal patients from the Northern Territory of Austrália. J Neurol Neurosurg Psychiatry 1978;41:874-881.
31. Van Brakel WH, Nicholls PG, Das L, et al. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline. Lepr Rev 2005;76:277-295.
32. Khambati FA, Shetty VP, Ghate SD, Capadia GD. Sensitivity and specificity of nerve palpation, monofilament testing and voluntary muscle testing in detecting peripheral nerve abnormality, using nerve conduction studies as gold standard; a study in 357 patients. Lepr Rev 2009;80:34-50.
33. Andrade GB. Aspectos neurofisiológicos da hanseníase [dissertação]. Ribeirão Preto (SP): Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo; 2010.
34. Capadia GD, Shetty VP, Khambati FA, Ghate SD. Effect of corticosteroid usage combined with multidrug therapy on nerve damage assessed using nerve conduction studies: a prospective cohort study of 365 untreated multibacillary leprosy patients. J Clin Neurophysiol 2010;27:38-47.
35. Brown TR, Kovindha A, Wathanadilokkol U, Piefer A, Smith T, Kraft GH. Leprosy neuropathy: correlation of clinical and electrophysiological tests. Indian J Lepr 1996;68:1-14.
36. De Faria CR, Silva IM. Electromyographic diagnosis of leprosy. Arq Neuropsiquiatr 1990;48:403-413.
37. Rao SP, Bharambe MS. Electroneurophysiological studies in early tuberculoid leprosy. Indian J Lepr 1993;65:181-187.
38. Husain S, Malaviya GN. Early nerve damage in leprosy: an electrophysiological study of ulnar and median nerves in patients with and without clinical neural deficits. Neurol India 2007;55:22-26.
39. Garbino JA, Naafs B, Ura S, Salgado MH, Virmond M. Neurophysiological patterns of ulnar nerve neuropathy in leprosy reactions. Lepr Rev 2010;81:206-215.
40. Van Brakel WH, Nicholls PG, Wilder-Smith EP, Das L, Barkataki P, Lockwood DNJ. Early diagnosis in leprosy - Comparing diagnostic tests in a large prospetive study (The INFIR cohort study). PLoS Neglected Trop Dis 2008;2:1-12.
41. Jardim MR, Antunes SL, Simons B, et al. Role of PGL-I antibody detection in the diagnosis of pure neural leprosy. Lepr Rev 2005;76:232-240.
42. Buhrer-Sekula HL, Smits GC, Gussenhoven J, et al. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 2003;41:1991-1995.
43. Moura RS, Calado KL, Oliveira MLW, Buhrer-Sekula S. Leprosy serology using PGL-I: a systematic review. Rev Soc Bras Med Trop 2008;41:S11-S18.
44. Grossi MA, Leboeuf MA, Andrade AR, Bührer-Sékula S, Antunes CM. Risk factors for ML Flow seropositivity in leprosy patients. Rev Soc Bras Med Trop 2008;41:S39-S44.
45. Lal H, Jain VK, Mittal RA, Chaudhary SD, Saini V. Detection of antibodies to phenolic glycolipid by ELISA in leprosy patients. Indian J Lepr 1993;65:95-99.
46. Zenha EM, Ferreira MA, Foss NT. Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients. Braz J Med Biol Res 2009;42:968-972.
47. De Freitas MRG, Nascimento OJM, De Freitas MR, Hahn MD. Isolated superficial peroneal nerve lesion in pure neural leprosy: case report. Arq Neuropsiquiatr 2004;62:535-539.
48. Laxmisha C, Thappa DM, Kumar MS, Joseph LC, Jayanthi S. Pure neural leprosy presenting with multiple nerve abscesses. Indian J Lepr 2004;76:343-350.
49. Martinez AN, Britto CFPC, Nery JAC, et al. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy. J Clin Microbiol 2006;44:3154-3159.
50. Bezerra da Cunha FM, Werneck MC, Scola RH, Werneck LC. Pure neural leprosy: diagnostic value of the polymerase chain reaction. Muscle Nerve 2006;33:409-414.
51. World Health Organization. A guide to eliminating leprosy as a public health problem. 2nd ed. Geneva: WHO; 1997, p. 106.
52. Barreto JA, Carvalho CV, Cury Filho M, Garbino JA, Nogueira MES, Soares CT. Hanseníase multibacilar com baciloscopia dos esfregaços negativa: a importância de se avaliar todos os critérios antes de se definir a forma clínica. Hansen Int 2007;32:75-79.
53. Murray CK, Joyce MP, Longfield RN. Short report: treatment failure in Hansen's disease. Am J Trop Hyg. 2003;68:233-234.
54. Rao NP, Suneetha S, Prata DVS. Comparative study of Uniform-MDT and WHO MDT in pauci and multi bacillary leprosy patients over 24 months of observation. Lepr Rev 2009;80:143-155.
55. Cairns WS, Smith WCS, Anderson AM, et al. Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomized placebo controlled trial (TRIPOD 1) BMJ 2004;328:1459.
56. Capadia GD, Shetty VP, Khambati FA, Ghate SD. Effect of corticosteroid usage combined with multidrug therapy on nerve damage assessed using nerve conduction studies: a prospective cohort study of 365 untreated multibacillary leprosy patients. J Clin Neurophysiol 2010;27:38-47.
57. Garbino JA, Virmond MCL, Ura S, Salgado MH, Naafs B. A randomized clinical trial of oral steroids for ulnar neuropathy in type 1 and type 2 leprosy reactions. Arq Neuropsiquiatr 2008;66:861-867
58. Van Brakel WH, Saunderson P, Shetty V, et al. International workshop on neuropathology in leprosy - consensus report. Lepr Rev 2007;78:416-433.
59. Sanderson P. The epidemiology of reactions and nerve damage. Workshop proceedings: leprosy research at the new millennium; Paris. Lepr Rev 2000;71(Suppl S):S106-S110.